Baiyang Wang

Title: Baiyang Wang: Innovator in Fusion Proteins and Antibody Development

Introduction

Baiyang Wang is a notable inventor based in Washington Crossing, PA (US). He has made significant contributions to the fields of biotechnology and pharmaceuticals, holding a total of 3 patents. His work primarily focuses on the development of fusion proteins and antibodies that have important applications in medical research and treatment.

Latest Patents

Wang's latest patents include innovative technologies such as transferrin fusion protein libraries. This invention involves fusion proteins that comprise a transferrin moiety and an integrin binding domain, along with peptide libraries derived from these proteins. The method described allows for the screening of transferrin and integrin peptide libraries displayed in fusion proteins expressed by host cells. Additionally, he has developed tissue factor antibodies that bind to human tissue factor without inhibiting tissue factor-mediated blood coagulation compared to a normal plasma control. This patent also outlines methods for making and using these antibodies.

Career Highlights

Throughout his career, Baiyang Wang has worked with prominent companies in the pharmaceutical industry, including Purdue Pharma L.P. and Biorexis Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in drug development and biopharmaceutical innovations.

Collaborations

Wang has collaborated with notable individuals in his field, including Andrew J. Turner and Andrew John Turner. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Baiyang Wang's contributions to the fields of fusion proteins and antibody development highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving therapeutic options and understanding complex biological processes.